NEW DELHI: A coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use was authorised by India’s drug regulator on Friday, two sources with knowledge of the matter said.
The decision clarifies the rollout of the vaccine in the world’s second-most populated region, which has the largest number of Covid-19 infections after the United States.
India wants to launch administration of the vaccine quickly, most likely by Wednesday, one of the sources said, both of whom declined to be identified in advance of an official announcement due later in the day.
A representative of the Central Drug Control Organization (CDSCO) of India, whose experts are meeting this week for the second time, refused to comment.
The AstraZeneca vaccine for immediate public use has already been approved by Britain and Argentina.
The CDSCO is also considering applications for emergency use authorisation for vaccines developed by Pfizer Inc with BioNTech in Germany and Bharat Biotech in India.